Paysign officer gets 233K-share stock award

Paysign, Inc.’s president of patient affordability reported a large restricted stock grant and related share dispositions for tax withholding on vesting.

Rhea-AI Filing Summary

Paysign, Inc. officer Turner Matthew Baker reported equity compensation and related tax transactions in Common Stock. On November 13, 2025, he received a grant of 233,333 shares of performance-based restricted stock, tied to an earnings target and vesting 1/3 on each of May 22, 2026, May 26, 2027, and May 24, 2028, subject to continued service. On February 3, 2026, he sold 15,057 shares at $4.16 per share, and on May 22, 2026, 50,681 shares at $6.72 per share were delivered or withheld, in both cases to satisfy tax withholding obligations on vesting restricted stock. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Seller: 15,057 shares

Net Sell 3 txns

Insider Turner Matthew Baker

Role PRES., PATIENT AFFORDABILITY

Sold 15,057 shs ($63K)

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F3	50,681	$6.72	$341K
Sale	Common Stock F2	15,057	$4.16	$63K
Grant/Award	Common Stock F1	233,333	$0.00	$0.00

Holdings After Transaction: Common Stock — 404,262 shares (Direct)

Footnotes (3)

1. F1. Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 22, 2026, May 26, 2027, and May 24, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date.
2. F2. Represents shares of common stock sold to satisfy certain tax withholding obligations associated with the vesting of restricted stock.
3. F3. Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock and performance-based restricted stock.

Key Figures

Performance-based restricted stock grant: 233,333 shares Sale shares for tax withholding: 15,057 shares at $4.16 per share Shares withheld for tax withholding: 50,681 shares at $6.72 per share +1 more

4 metrics

Performance-based restricted stock grant 233,333 shares Granted on November 13, 2025 after an earnings target was achieved

Sale shares for tax withholding 15,057 shares at $4.16 per share Common stock sold on February 3, 2026 to satisfy tax withholding obligations

Shares withheld for tax withholding 50,681 shares at $6.72 per share Common stock withheld on May 22, 2026 to satisfy tax withholding obligations

Vesting schedule installments 3 installments Restricted stock vests 1/3 on May 22, 2026, May 26, 2027, and May 24, 2028

Key Terms

performance-based restricted stock, vesting, tax withholding obligations, withheld by the issuer

4 terms

performance-based restricted stock financial

"Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied"

Shares granted to employees or executives that are held back and only become actual, tradable stock if the company meets predefined performance targets; until those goals are met the shares cannot be sold. Think of it like a bonus held in escrow that’s released only when specific results are achieved — investors watch these awards because they tie management pay to company outcomes, can dilute existing shareholders when released, and signal how confident or incentivized insiders are to meet growth or profitability goals.

vesting financial

"The restricted stock will vest and be delivered as to 1/3 of the shares"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

tax withholding obligations financial

"sold to satisfy certain tax withholding obligations associated with the vesting of restricted stock"

withheld by the issuer financial

"shares of common stock withheld by the issuer to satisfy certain tax withholding obligations"

FAQ

What insider equity award did PAYS grant to Turner Matthew Baker?

Turner Matthew Baker received a grant of 233,333 shares of performance-based restricted stock on November 13, 2025, with vesting in three equal installments in 2026, 2027, and 2028, after an earnings target was achieved and subject to his continued service.

When do Turner Matthew Baker’s PAYS restricted shares vest?

The 233,333 performance-based restricted shares vest and are delivered in three equal parts on May 22, 2026, May 26, 2027, and May 24, 2028, provided Turner Matthew Baker continues to serve Paysign through each applicable vesting date.

What PAYS share sale did Turner Matthew Baker report on February 3, 2026?

On February 3, 2026, Turner Matthew Baker sold 15,057 shares of Paysign common stock at a price of $4.16 per share. A footnote states the shares were sold to satisfy certain tax withholding obligations from the vesting of restricted stock.

What tax-withholding share transaction did PAYS report for May 22, 2026?

On May 22, 2026, 50,681 shares of Paysign common stock valued at $6.72 per share were withheld by Paysign to satisfy tax withholding obligations related to the vesting of restricted and performance-based restricted stock held by Turner Matthew Baker.

Were Turner Matthew Baker’s PAYS transactions under a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not checked, and there is no footnote indicating a trading plan, so these reported transactions are not stated to be made under a Rule 10b5-1 trading plan.

What role does Turner Matthew Baker hold at Paysign, Inc. (PAYS)?

Turner Matthew Baker is reported as an officer of Paysign, Inc., with the title President, Patient Affordability, in connection with these equity award and tax-withholding transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/04/2026 - 06:43 PM Accepted by SEC EDGAR 09/04/2026 - 06:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Turner Matthew Baker

(Last) (First) (Middle)

2615 ST ROSE PARKWAY

(Street)

HENDERSON NEVADA 89052

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Paysign, Inc. [ PAYS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRES., PATIENT AFFORDABILITY

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/13/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/13/2025		A		233,333(1)	A	$0.00	470,000	D
Common Stock	02/03/2026		S(2)		15,057	D	$4.16	454,943	D
Common Stock	05/22/2026		F(3)		50,681	D	$6.72	404,262	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents performance-based restricted stock granted on May 7, 2025, with the performance goal deemed satisfied on November 13, 2025 based upon the achievement of a specified earnings target. The restricted stock will vest and be delivered as to 1/3 of the shares on each of May 22, 2026, May 26, 2027, and May 24, 2028, subject to the reporting person's continued service to the issuer through and on the applicable vesting date.

2. Represents shares of common stock sold to satisfy certain tax withholding obligations associated with the vesting of restricted stock.

3. Represents shares of common stock withheld by the issuer to satisfy certain tax withholding obligations associated with the vesting of restricted stock and performance-based restricted stock.

	/s/ Matthew Baker Turner	09/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)